Litigation Details for Teva Pharmaceuticals USA Inc. v. AstraZeneca Pharmaceuticals LP (D. Del. 2015)
✉ Email this page to a colleague
Teva Pharmaceuticals USA Inc. v. AstraZeneca Pharmaceuticals LP (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-01-18 |
| Court | District Court, D. Delaware | Date Terminated | 2016-09-28 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,858,576; 6,872,700; 6,902,744; 6,956,026; 7,297,761; 7,521,423; 7,741,269 | ||
| Link to Docket | External link to docket | ||
Details for Teva Pharmaceuticals USA Inc. v. AstraZeneca Pharmaceuticals LP (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-01-18 | 1 | other patents listed in the Orange Book with respect to Byetta® are U.S. Patent Nos. 6,858,576 (“the …United States Patent Nos. 7,297,761 (“the ‘761 patent”) and 7,741,269 (“the ‘269 patent”). 2.…the ‘576 patent”), 6,872,700 (“the ‘700 patent”), 6,956,026 (“the ‘026 patent”), 6,902,744 (“the ‘744 patent…Defendants listed the ‘761 and ‘269 patents, together with six other patents, in the U.S. Food and Drug Administration…seven of the patents listed in the Orange Book for Byetta®, including the ‘761 and ‘269 patents. Teva USA | External link to document | |
| 2015-01-18 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,297,761 B2; US 7,741,269 … 28 September 2016 1:15-cv-00050 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
